Lake Street Capital Begins Coverage on Biodesix (NASDAQ:BDSX)

Lake Street Capital assumed coverage on shares of Biodesix (NASDAQ:BDSX – Free Report) in a report issued on Friday, Marketbeat reports. The brokerage issued a buy rating and a $3.00 price target on the stock. Separately, Canaccord Genuity Group reaffirmed a buy rating and set a $3.50 target price on shares of Biodesix in a […]

Related Keywords

United States ,Scott Hutton ,Securities Exchange Commission ,Biodesix Inc ,Oracle Investment Management Inc ,Canaccord Genuity Group ,Essex Investment Management Co ,Opaleye Management Inc ,Lake Street Capital ,Free Report ,Get Free Report ,Exchange Commission ,Investment Management ,Oracle Investment Management ,Nodify Lung Nodule Risk Assessment ,Biodesix Daily ,Biodesix ,Nasdaq Bdsx ,Bdsx ,Medical ,Initiated Coverage ,